Find clinical trials for Multiple Sclerosis (MS) in Miami, FL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Multiple Sclerosis

Sclerosis

Chronic Progressive Multiple Sclerosis

Relapsing-Remitting Multiple Sclerosis

Autoimmune Diseases

Neoplasm Metastasis

Alzheimer Disease

Multiple Sclerosis (MS) trials near Miami, FL, USA:

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

To evaluate the safety and efficacy of fingolimod vs. interferon beta-1a i.m. in pediatric patients with multiple sclerosis (MS...

Active, not recruiting

Multiple Sclerosis

Drug: Interferon beta-1a

Drug: Placebo capsule

Phase 3

Novartis

Miami, Florida, United States and 72 other locations

A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS) (FUSION)

In this study, researchers will learn more about a study drug called BIIB091 in participants with MS who may be experiencing relapses. It is...

Enrolling

Relapsing Forms of Multiple Sclerosis

Drug: BIIB091

Drug: DRF

Phase 2

Biogen

Miami, Florida, United States and 76 other locations

Locations recently updated

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation (SOSTOS)

This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...

Enrolling

Relapsing-Remitting Multiple Sclerosis

Drug: Disease modifying treatment (DMT)

Drug: Ofatumumab

Phase 4

Novartis

Homestead, Florida, United States and 41 other locations

Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls. (AGNOS)

This study will evaluate the impact of ofatumumab in Relapsing Remitting Multiple Sclerosis (RRMS) participants that are very early...

Active, not recruiting

Relapse Remitting Multiple Sclerosis

Drug: Ofatumumab

Phase 4

Novartis

Boca Raton, Florida, United States of America and 35 other locations

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

Enrolling

Relapsing Multiple Sclerosis

Drug: Teriflunomide

Drug: Remibrutinib

Phase 3

Novartis

Miami, Florida, United States and 241 other locations

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)

To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...

Enrolling

Relapsing Multiple Sclerosis

Drug: Remibrutinib

Drug: Teriflunomide

Phase 3

Novartis

Miami, Florida, United States and 237 other locations

Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis

derived human stromal cells, in treating Secondary Progressive Multiple Sclerosis (SPMS), compared to placebo.The study will assess...

Begins enrollment in 2 months

Secondary Progressive Multiple Sclerosis (SPMS)

Other: Sodium Chloride 0.9%

Biological: NG01 - Autologous bone marrow derived human stromal cells

Phase 2

NeuroGenesis Ltd.

Miami, Florida, United States and 1 other location

Locations recently updated

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

This is a Phase 3 extension, global, multicenter study to assess the long-term safety and tolerability of tolebrutinib in adult participants (aged ≥1...

Enrolling

Secondary Progressive Multiple Sclerosis

Relapsing Multiple Sclerosis

Drug: Teriflunomide

Drug: Placebo

Phase 3

Sanofi

Miami, Florida, United States and 315 other locations

Locations recently updated

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS (ALITHIOS)

) neo-antigen in subjects with relapsing multiple sclerosis (RMS).COVID-19 sub-study:The purpose of this research sub-study is to e...

Active, not recruiting

Relapsing Multiple Sclerosis

Biological: 23-valent pneumococcal polysaccharide vaccine (23-PPV)

Biological: Tetanus toxoid (TT) containing vaccine (Td, Tdap)

Phase 3

Novartis

Miami, Florida, United States and 298 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Multiple Sclerosis (MS) in .css-epvm6{white-space:nowrap;}Miami, FL

Related conditions:

Multiple Sclerosis (MS) trials near Miami, FL, USA:

Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

A Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS) (FUSION)

A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation (SOSTOS)

Study to Assess the Effect of Ofatumumab in Treatment Naïve, Very Early RRMS Patients Benchmarked Against Healthy Controls. (AGNOS)

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-2)

Study of NG01 Cell Therapy in Secondary Progressive Multiple Sclerosis

A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.

Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS (ALITHIOS)

Find clinical trials for Multiple Sclerosis (MS) in Miami, FL